All three major US stock indexes were down in late-morning trading Tuesday, as concerns mount over valuations of artificial intelligence-heavy companies.
In company news, Uber Technologies (UBER) reported Q3 earnings Tuesday of $3.11 per diluted share, up from $1.20 a year earlier. Third-quarter revenue was $13.47 billion, up from $11.19 billion a year ago and above the FactSet consensus analyst estimate of $13.28 billion. For Q4, Uber said it expects gross bookings of $52.25 billion to $53.75 billion, which would reflect growth of 17% to 21% annually on a constant currency basis. Uber shares were down 7.2% around midday.
Palantir Technologies (PLTR) reported Q3 adjusted earnings late Monday of $0.21 per diluted share, above the FactSet consensus estimate of $0.17. Third-quarter revenue was $1.18 billion, up from $725.5 million a year ago and above the FactSet consensus of $1.09 billion. For Q4, Palantir said it expects revenue around $1.33 billion, above the FactSet consensus of $1.18 billion. For full-year 2025, the company said it expects revenue of $4.39 billion to $4.40 billion, up from its previous guidance of $4.14 billion to $4.15 billion and above the FactSet consensus of $4.14 billion. Palantir shares were down 7.6%.
Metsera (MTSR) said Tuesday its board received an amended acquisition proposal from Novo Nordisk (NVO) that its board determined constitutes a "Superior Company Proposal" as defined under its existing merger agreement with Pfizer (PFE). The revised proposal values Metsera at up to $10.0 billion, or up to $86.20 per share. Metsera also said Pfizer revised its own offer on Monday to $60 per share in cash, up from $47.50, while reducing the contingent value right to up to $10 per share in cash, down from $22.50. Separately, Pfizer reported Q3 adjusted earnings Tuesday of $0.87 per diluted share, down from $1.06 a year earlier but above the FactSet consensus of $0.63. Third-quarter revenue was $16.65 billion, down from $17.70 billion a year ago but above the FactSet consensus of $16.50 billion. For full-year 2025, the company said it expects adjusted diluted EPS of $3 to $3.15, up from its previous guidance of $2.90 to $3.10. Analysts surveyed by FactSet expect $3.04. Metsera shares were up 19%, while those of Novo Nordisk and Pfizer were down 1.6% and 0.4%, respectively.
Tesla (TSLA) shareholder Norges Bank Investment Management voted against the proposed $1 trillion compensation package for Chief Executive Elon Musk. Tesla shares were down 3%.
Yum! Brands (YUM) reported Q3 non-GAAP earnings Tuesday of $1.58 per share, up from $1.37 a year earlier and above the FactSet consensus of $1.49. Third-quarter revenue was $1.98 billion, up from $1.83 billion a year ago but below the FactSet consensus of $2 billion. The company said it started a review of strategic options for its Pizza Hut brand. Yum! shares were up 6.8%.
Ferrari (RACE) reported Q3 adjusted earnings Tuesday of 2.14 euros ($2.46) per diluted share, up from 2.08 euros a year earlier and above the consensus estimate of two analysts surveyed by FactSet of 2.09 euros. Third-quarter net revenue was 1.77 billion euros, up from 1.64 billion euros a year ago and above the FactSet consensus of 1.70 billion euros. For full-year 2025, the company expects adjusted EPS of at least 8.80 euros, up from its prior guidance of 8.60 euros. Analysts expect 8.92 euros. Ferrari shares were up 3.2%.
Hertz Global (HTZ) reported Q3 adjusted earnings Tuesday of $0.12 per diluted share, up from a loss of $0.68 a year earlier and above the FactSet consensus of $0.00. Third-quarter revenue was $2.48 billion, down from $2.58 billion a year ago but above the FactSet consensus of $2.39 billion. Hertz shares were up 38.8%.
Price: 92.53, Change: -7.19, Percent Change: -7.21
Comments